open access

Vol 59, No 6 (2008)
Review paper
Submitted: 2013-02-15
Published online: 2008-10-30
Get Citation

Central precocious puberty

Robert Krysiak, Bogdan Marek, Bogusław Okopień
Endokrynol Pol 2008;59(6):530-540.

open access

Vol 59, No 6 (2008)
Reviews — Postgraduate Education
Submitted: 2013-02-15
Published online: 2008-10-30

Abstract

Central precocious puberty, defined as the onset of puberty before the age 8 years in girls and 9 years in boys, results from a premature activation of gonadotropin-releasing hormone neurons in the hypothalamus. This condition is characterised by early pubertal changes, acceleration of growth velocity, and rapid bone maturation that often result in reduced adult height. It may be either idiopathic or associated with hypothalamic hamartoma, brain neoplasms, numerous non-cancerous disorders of the central nervous system and treatment of peripheral precocious puberty. The goal of the initial assessment of children is to exclude the presence of all these organic disorders. The diagnosis should include detailed anamnesis and clinical examination, measurement of pituitary and sex hormones, assessment of bone age, and imaging of the hypothalamus, pituitary gland, abdomen, pelvis and gonads. The treatment of choice are gonadotropin-releasing hormone agonists. In this paper, we review the current views on the etiopathogenesis, clinical presentation, diagnosis and management of central precocious puberty.

Abstract

Central precocious puberty, defined as the onset of puberty before the age 8 years in girls and 9 years in boys, results from a premature activation of gonadotropin-releasing hormone neurons in the hypothalamus. This condition is characterised by early pubertal changes, acceleration of growth velocity, and rapid bone maturation that often result in reduced adult height. It may be either idiopathic or associated with hypothalamic hamartoma, brain neoplasms, numerous non-cancerous disorders of the central nervous system and treatment of peripheral precocious puberty. The goal of the initial assessment of children is to exclude the presence of all these organic disorders. The diagnosis should include detailed anamnesis and clinical examination, measurement of pituitary and sex hormones, assessment of bone age, and imaging of the hypothalamus, pituitary gland, abdomen, pelvis and gonads. The treatment of choice are gonadotropin-releasing hormone agonists. In this paper, we review the current views on the etiopathogenesis, clinical presentation, diagnosis and management of central precocious puberty.
Get Citation

Keywords

central precocious puberty; etiopathogenesis; clinical manifestation; diagnosis; treatment

About this article
Title

Central precocious puberty

Journal

Endokrynologia Polska

Issue

Vol 59, No 6 (2008)

Article type

Review paper

Pages

530-540

Published online

2008-10-30

Page views

688

Article views/downloads

6177

Bibliographic record

Endokrynol Pol 2008;59(6):530-540.

Keywords

central precocious puberty
etiopathogenesis
clinical manifestation
diagnosis
treatment

Authors

Robert Krysiak
Bogdan Marek
Bogusław Okopień

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą jest  VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl